SAWAI GROUP HOLDINGS Co., Ltd. Logo

SAWAI GROUP HOLDINGS Co., Ltd.

Pharmaceutical holding company that develops and markets generic and OTC drugs.

4887 | T

Overview

Corporate Details

ISIN(s):
JP3323040000
LEI:
Country:
Japan
Address:
大阪市淀川区宮原5丁目2−30

Description

SAWAI GROUP HOLDINGS Co., Ltd. is a holding company that operates through its subsidiaries in the pharmaceutical field. The group's core activities encompass the research, development, manufacture, and marketing of medical products. It is primarily known for its extensive portfolio of high-quality generic pharmaceuticals, which serve as bioequivalent alternatives to branded drugs across various therapeutic areas, including treatments for hypertension, dyslipidemia, and diabetes. In addition to prescription generics, the company also handles over-the-counter (OTC) and other ethical drugs. The group is committed to enhancing healthcare access and affordability by providing reliable and cost-effective medications to patients and medical professionals.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-05 03:06
発行登録追補書類(株券、社債券等)
Japanese ZIP 87.5 KB
2025-11-14 07:13
確認書
Japanese ZIP 9.1 KB
2025-11-14 07:12
半期報告書-第5期(2025/04/01-2026/03/31)
Japanese ZIP 335.3 KB
2025-10-31 03:04
訂正発行登録書
Japanese ZIP 24.2 KB
2025-06-27 02:47
訂正発行登録書
Japanese ZIP 10.0 KB
2025-06-26 07:49
臨時報告書
Japanese ZIP 31.2 KB
2025-06-24 08:06
内部統制報告書-第4期(2024/04/01-2025/03/31)
Japanese ZIP 24.3 KB
2025-06-24 08:06
確認書
Japanese ZIP 9.0 KB
2025-06-24 08:05
有価証券報告書-第4期(2024/04/01-2025/03/31)
Japanese ZIP 2.0 MB
2025-05-27 05:40
訂正発行登録書
Japanese ZIP 9.6 KB
2025-05-27 02:50
臨時報告書
Japanese ZIP 20.1 KB
2025-04-03 06:28
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 23.4 KB
2025-03-05 07:02
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 27.8 KB
2025-02-05 07:08
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 28.2 KB
2025-01-08 07:53
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 27.7 KB

Automate Your Workflow. Get a real-time feed of all SAWAI GROUP HOLDINGS Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAWAI GROUP HOLDINGS Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAWAI GROUP HOLDINGS Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.